Experienced in Methicillin-Resistant Staphylococcus Aureus (MRSA)

Dr. Sandeep K. Gupta

Internal Medicine
Community Physicians Of Indiana Inc
7250 Clearvista Dr, Suite 355, 
Indianapolis, IN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Methicillin-Resistant Staphylococcus Aureus (MRSA)
Community Physicians Of Indiana Inc
7250 Clearvista Dr, Suite 355, 
Indianapolis, IN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sandeep Gupta is a primary care provider, practicing in Internal Medicine in Indianapolis, Indiana. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Eosinophilic Esophagitis, Eosinophilic Enteropathy, Esophagitis, Endoscopy, and Colonoscopy. Dr. Gupta is currently accepting new patients.

His clinical research consists of co-authoring 143 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Methicillin-Resistant Staphylococcus Aureus (MRSA).

Specialties
Internal Medicine
Licenses
Internal Medicine in PA
Hospital Affiliations
Community Hospital North
Community Hospital East
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 12 Less Insurance Carriers -

Locations

COMMUNITY PHYSICIANS OF INDIANA INC
7250 Clearvista Dr, Suite 355, Indianapolis, IN 46256

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
Enrollment Status: Recruiting
Publish Date: September 12, 2025
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
Enrollment Status: Active_not_recruiting
Publish Date: August 05, 2024
Intervention Type: Drug
Study Drug: Dupilumab
Study Phase: Phase 2
Phase 2 Study of Esophageal String Test in Diagnosing Eosinophilic Esophagitis
Phase 2 Study of Esophageal String Test in Diagnosing Eosinophilic Esophagitis
Enrollment Status: Active_not_recruiting
Publish Date: March 29, 2024
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Enrollment Status: Completed
Publish Date: September 28, 2021
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

143 Total Publications

Pediatric Vaccine Hesitancy in the United States-The Growing Problem and Strategies for Management Including Motivational Interviewing.
Pediatric Vaccine Hesitancy in the United States-The Growing Problem and Strategies for Management Including Motivational Interviewing.
Journal: Vaccines
Published: December 13, 2024
Similar Doctors
Experienced in Methicillin-Resistant Staphylococcus Aureus (MRSA)
Dr. Zhi J. Xu
Family Medicine | Internal Medicine
Experienced in Methicillin-Resistant Staphylococcus Aureus (MRSA)
Dr. Zhi J. Xu
Family Medicine | Internal Medicine

Reid Physician Associates Inc

1100 Reid Pkwy, 
Richmond, IN 
 (61.3 miles away)
765-983-3122
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

Zhi Xu is a primary care provider, practicing in Family Medicine and Internal Medicine in Richmond, Indiana. Dr. Xu is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Low Sodium Level, Chronic Cough, Ureteroscopy, and Hip Replacement. Dr. Xu is currently accepting new patients.

Experienced in Methicillin-Resistant Staphylococcus Aureus (MRSA)
Dr. Ramesh Prajapati
Internal Medicine
Experienced in Methicillin-Resistant Staphylococcus Aureus (MRSA)
Dr. Ramesh Prajapati
Internal Medicine

Indiana University Health Ball Memorial Physicians Inc

2401 W University Ave, 
Muncie, IN 
 (38.9 miles away)
765-747-3111
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ramesh Prajapati is a primary care provider, practicing in Internal Medicine in Muncie, Indiana. Dr. Prajapati is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Pneumonia, Peptic Ulcer, Hip Replacement, and Ureteroscopy. Dr. Prajapati is currently accepting new patients.

Experienced in Methicillin-Resistant Staphylococcus Aureus (MRSA)
Dr. William J. Schmalz
Internal Medicine
Experienced in Methicillin-Resistant Staphylococcus Aureus (MRSA)
Dr. William J. Schmalz
Internal Medicine
3209 W Fullerton Pike, Suite E, 
Bloomington, IN 
 (60.9 miles away)
812-825-6102
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Schmalz is a primary care provider, practicing in Internal Medicine in Bloomington, Indiana. Dr. Schmalz is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are High Cholesterol, Sitosterolemia, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Endoscopy. Dr. Schmalz is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gupta's expertise for a condition
ConditionClose
View All 66 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile